Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Prodrugs01:30

Prodrugs

2.6K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
2.6K
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

70.6K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
70.6K
Antibiotic Selection00:57

Antibiotic Selection

53.2K
Overview
53.2K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Drug Nomenclature01:17

Drug Nomenclature

1.7K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.7K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.4K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Rational design of indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors featuring 1,2,3-triazole derivatives with enhanced anti-inflammatory and analgesic efficacy.

Frontiers in pharmacology·2025
Same author

Tonoplast sugar transporter StTST1 mediates vacuolar sugar partitioning and abiotic stress tolerance in potato.

Plant physiology and biochemistry : PPB·2025
Same author

Physical Properties of Mold Flux and Mineralogical Characteristics of Flux Film for Low-alloy Peritectic Steel Continuous Casting.

Materials (Basel, Switzerland)·2025
Same author

Regulation of osteogenic differentiation in vascular smooth muscle cells under high-glucose condition.

Frontiers in endocrinology·2025
Same author

Accurate structure prediction of cyclic peptides containing unnatural amino acids using HighFold3.

Briefings in bioinformatics·2025
Same author

Silibinin accelerates diabetic wound healing through PI3K/Akt-mediated immunomodulation-angiogenesis crosstalk.

Biochemical and biophysical research communications·2025

相关实验视频

Updated: Jun 26, 2025

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

10.8K

PharmaRedefine:一个数据库服务器,用于对抗病原细菌的药物重新定位.

Longxiao Yuan1, Jingjing Guo1

  • 1Centre in Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999097, China.

Methods (San Diego, Calif.)
|May 16, 2024
PubMed
概括

这项研究介绍了PharmaRedefine,这是一个在线工具,用于对病原细菌进行药物重新定位. 它通过识别类似的蛋白质标来预测FDA批准的药物的新用途,有助于打击抗生素耐药性.

科学领域:

  • 微生物学 微生物学
  • 药物发现 药物发现 药物发现
  • 生物信息学是一种生物信息学.

背景情况:

  • 致病性细菌构成了严重的全球健康威胁,因抗生素耐药性增加而加剧.
  • 创新策略对于开发针对细菌感染的新疗法至关重要.
  • 药物再利用为识别新型抗菌疗法提供了一个可行的途径.

研究的目的:

  • 开发一种计算方法来识别现有药物的潜在细菌点.
  • 推出PharmaRedefine,一个在线服务器,促进对病原细菌的药物重新定位.
  • 为了利用蛋白质 - 配体结合口袋的相似性来预测药物向相互作用.

主要方法:

  • 使用序列和结构对齐算法.
  • 进行蛋白质口袋相似性分析.
  • 将这些方法集成到PharmaRedefine在线平台中.

主要成果:

  • 通过PharmaRedefine,可以预测FDA批准的药物的潜在细菌点.
  • 服务器促进了对抗细菌感染的药物重新定位策略.
  • 确定了各种致病细菌的潜在药物向相互作用.
关键词:
数据库数据库数据库是一个数据库.药物重新定位是药物重新定位.致病性细菌是一种病原性细菌.

更多相关视频

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.2K

相关实验视频

Last Updated: Jun 26, 2025

Antibiotic Dereplication Using the Antibiotic Resistance Platform
10:49

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

10.8K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

14.2K

结论:

  • PharmaRedefine是加速对抗细菌病原体的药物重新定位工作的宝贵资源.
  • 这种方法有望发现现有药物的新疗法应用.
  • 这一战略可以帮助克服抗生素耐药性的挑战.